SCHEMBL14718487

SCHEMBL14718487

CCn1nc(Oc2ccc(C(F)(F)F)cc2)c(F)c1-c1cccc(C#N)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.39
TRPA1 O75762 1/20 0.38
MAT2A P31153 1/20 0.37
KIF11 P52732 1/20 0.36
SCN9A Q15858 2/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
PTPN5 P54829 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PDE10A Q9Y233 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35
MCTS1 Q9ULC4 1/20 0.35
CTSS P25774 3/20 0.34
CTSK P43235 3/20 0.34
MRGPRX4 Q96LA9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1659949 0.81 SCN9A (0.42) PTGDR2TRPA1MAT2AKIF11SCN9A
SCHEMBL1659863 0.80 BRD9 (0.31) SCN9A
SCHEMBL1661561 0.80 PTGDR2 (0.40) PTGDR2TRPA1MAT2AKIF11SCN9A
SCHEMBL1661617 0.73 MMP2 (0.33) SCN9A
SCHEMBL1658717 0.71 KIF11 (0.36) KIF11SCN9AKDM4ELMNACTSS
SCHEMBL1659890 0.70 GABRG2 (0.40) TRPA1SCN9AKDM4ELMNAL3MBTL1
SCHEMBL1660602 0.70 GABRG2 (0.42) SCN9ACTSSCTSK
SCHEMBL5387429 0.68 PTGS1 (0.45) SCN9ASLC16A3SLC16A1MCTS1
SCHEMBL6724296 0.67 F10 (0.50) KIF11KDM4EHTTSMN1; SMN2
SCHEMBL14718164 0.66 LMNA (0.35) SCN9AKDM4ELMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871796-B2 Diaryl ether derivatives as notch sparing gamma secretase inhibitors MERCK SHARP & DOHME CORP. (US) 2014-10-28 US disclosed
US-8871796-B2 Diaryl ether derivatives as notch sparing gamma secretase inhibitors MERCK SHARP & DOHME CORP. (US) 2014-10-28 US disclosed
US-20130053386-A1 DIARYL ETHER DERIVATIVES AS NOTCH SPARING GAMMA SECRETASE INHIBITORS MERCK SHARP & DOHME LLC 2013-02-28 US disclosed
US-20130053386-A1 DIARYL ETHER DERIVATIVES AS NOTCH SPARING GAMMA SECRETASE INHIBITORS MERCK SHARP & DOHME LLC 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053386-A1 DIARYL ETHER DERIVATIVES AS NOTCH SPARING GAMMA SECRETASE INHIBITORS BACE1, BACE2, GSAP PTGDR2 1751/4885TRPA1 2928/4885MAT2A 2125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.